Compounded Semaglutide

Compounded Semaglutide - Revolutionary Weight Loss

• A simple, once-weekly GLP-1 injection designed for effective weight loss.
• Contains the same active ingredient as Ozempic® and Wegovy®—at a fraction of the cost.

Key Ingredient

• Semaglutide: .25 mg up to 2.5 mg per dose.

How It Works

• Semaglutide is a GLP-1 receptor agonist that mimics the body’s natural GLP-1 hormone.
• It works in two main ways:
  • Slows stomach emptying, which increases feelings of fullness and reduces food intake. 
  • Boosts insulin secretion, helping to lower blood glucose levels.

Health Benefits:

• Effective Weight Loss: Semaglutide has been shown to help individuals lose up to 20% of their body weight.**
  
• Appetite Control: Helps you feel fuller for longer, curbing unnecessary cravings and supporting healthier eating habits.
• Blood Sugar Balance: Enhances your body’s natural response to sugar, promoting healthy glucose levels.
  
• Metabolic Support: Contributes to sustainable, long-term improvements in metabolic health.
  

Longevity Benefits:

• Obesity rates in the U.S. have reached alarming levels, with nearly 73% of adults now classified as overweight or obese.¹² Research clearly links excess weight to a reduced lifespan, with severe or class III obesity (BMI 40-59) potentially shortening life expectancy by up to 14 years.^13,14 This stark reality underscores the urgent need for effective weight management strategies to support healthy aging. 
• Exciting new research is uncovering the extraordinary potential of GLP-1s, highlighting benefits that extend well beyond weight loss. While these compounds are highly effective in achieving and maintaining a healthy weight, they are gaining recognition for their profound influence on the fundamental mechanisms of aging. Preclinical studies demonstrate their capacity to extend both healthspan and lifespan in various model organisms.
• Key anti-aging benefits of GLP-1s include:
  • Reducing oxidative stress and inflammation.
  • Enhancing cellular repair through autophagy.
  • Protecting against cellular senescence.
  • Boosting mitochondrial function.
  • Improving skin hydration and wrinkles.
  • Strengthening bones and joints.
  • Enhancing cognitive function and neuroprotection.
  • Promoting cardiovascular health.
• These effects are driven by advanced biological mechanisms, including the activation of AMPK (a key energy regulator), inhibition of the mTOR pathway (linked to aging and cellular stress), and modulation of Nrf2 signaling (critical for antioxidant defenses). By targeting key hallmarks of aging and influencing multiple longevity pathways, GLP-1s have the potential to become a groundbreaking tool in advancing healthy aging.

Why Choose ProHealth Longevity?

• Same-day prescription approval
• No insurance required
  
• Compounded by a US-licensed pharmacy
• Lab tested for quality and safety
• Expedited (two-day) shipping
• Delivered directly to your home
• In stock, ready to ship

Reach Your Weight Goals in 4 Simple Steps:

1. Health Questionnaire: Fill out a quick, five-minute online health history form.
2. Doctor Review: A licensed medical professional will review your form to confirm eligibility.
3. Expedited Shipping: Once approved, your prescription will be prepared and shipped from a US-licensed, FDA-regulated pharmacy.
4. At-Home Support: Receive 24/7 access to our care team through phone, text, or email for personalized guidance every step of the way.

*Please note that the product packaging may differ from the image shown.

**In multiple clinical trials, Semaglutide has consistently delivered significant weight loss results, with participants achieving an average reduction of 10-16% in body weight. Notably, up to 33% of individuals experienced substantial weight loss of 20% or more. These outcomes may be further enhanced when combined with diet, exercise, and behavioral counseling. Individual results may vary.^1-11

References:

1. Wilding J et al. New England Journal of Medicine. 2021;384:989-1002. (STEP 1 Trial) 
2. Davies M et al. Lancet. 2021;397(10278):971-984. (STEP 2 Trial)
3. Wadden TA et al. JAMA. 2021;325(14):1403-1413. (STEP 3 Trial)
4. Rubino D et al. JAMA. 2021;325(14):1414-1425. (STEP 4 Trial)
5. Garvey WT et al. Nat Med. 2022;28(10):2083-2091. (STEP 5 Trial)
6. Kadowaki T et al. Lancet Diabetes Endocrinol. 2022;10(3):193-206. (STEP 6 Trial)
7. Mu Y et al. Lancet Diabetes Endocrinol. 2024;12(3):184-195. (STEP 7 Trial)
8. Rubino DM et al. JAMA. 2022;327(2):138-150. (STEP 8 Trial)
9. Bliddal H et al. N Engl J Med. 2024;391(17):1573-1583. (STEP 9 Trial)
10. McGowan BM et al. Lancet Diabetes Endocrinol. 2024;12(9):631-642. (STEP 10 Trial) 
11. Moiz A et al. Am J Cardiol. 2024;222:121-130. (Review and Meta-Analysis)
12. O'Keefe J, et al. Cardiovasc Dis. Dec 2024;30:S0033-0620(24)00179-8.
13. Kitahara CM et al., PLoS Med. 2014;11(7):e1001673.
14. Abdelaal M et al. Ann Transl Med. 2017;5(7):161.